InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Exchange Rate Effect (2016 - 2026)

InflaRx's (IFRX) quarterly Exchange Rate Effect came in at $2.3 million in Q2 2026, up 219.08% year-over-year from $728221.9 in Q2 2025, and up 561.18% quarter-over-quarter from $351429.7 in Q1 2026.

Analysis

InflaRx (IFRX) Exchange Rate Effect (2016 - 2026) Analysis & Trends

InflaRx has disclosed Exchange Rate Effect across 11 years of filings, most recently posting $2.3 million for Q2 2026.

  • In Q2 2026, Exchange Rate Effect rose 219.08% year-over-year to $2.3 million; the TTM figure through Jun 2026 stood at $2.5 million (up 184.99% YoY), while the FY2025 annual figure was -$4.1 million, down 368.39% from the prior year.
  • Exchange Rate Effect came in at $2.3 million for Q2 2026 at InflaRx, up from $351429.7 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $2.3 million in Q2 2026 to a low of -$2.0 million in Q2 2025.
  • Average Exchange Rate Effect over 5 years is $101050.4, with a median of $64410.5 recorded in 2025.
  • Year-over-year, Exchange Rate Effect soared 463.79% in 2024 and sank 710.66% in 2025.
  • Over 5 years, Exchange Rate Effect stood at -$523806.2 in 2022, then slumped by 60.92% to -$842905.3 in 2023, then soared by 281.52% to $1.5 million in 2024, then plunged by 107.02% to -$107348.1 in 2025, then soared by 2264.54% to $2.3 million in 2026.
  • Per Business Quant data, the three most recent Exchange Rate Effect figures were $2.3 million in Q2 2026, $351429.7 in Q1 2026, and -$107348.1 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -19.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -3.70 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -300,000.00
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -2.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -2.45 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -3.40 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 315,000.00
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn -22,403.36
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.32 Mn
Mar 31, 2026 351,429.75
Dec 31, 2025 -107,348.09
Sep 30, 2025 -40,102.10
Jun 30, 2025 -1.95 Mn
Mar 31, 2025 -1.83 Mn
Dec 31, 2024 1.53 Mn
Sep 30, 2024 -723,771.68
Jun 30, 2024 319,540.54
Mar 31, 2024 374,122.35
Dec 31, 2023 -842,905.31
Sep 30, 2023 168,923.12
Jun 30, 2023 -272,283.37
Mar 31, 2023 -102,841.17
Dec 31, 2022 -523,806.22
Sep 30, 2022 829,689.79
Jun 30, 2022 1.96 Mn
Mar 31, 2022 353,131.22
Dec 31, 2021 1.96 Mn
Sep 30, 2021 2.22 Mn